Transfemoral Access for Large-Bore Interventions

  • George V. MoukarbelEmail author
  • Frederic S. Resnic


Interventions requiring large-bore access have been rapidly increasing in recent years with the dramatic growth of transcatheter aortic valve replacement (TAVR), use of adjunctive mechanical ventricular support systems, and expanded use of endovascular treatment of aortic disease. Typically these procedures require the use of sheaths ranging from 10 to 24 French in size. The common femoral artery can provide an appropriate access site for such procedures. Adequate anatomical characteristics of the common femoral and iliac arteries can be determined by angiography. Complete percutaneous access and closure are possible with the use of a careful technique and appropriate devices. A preclosure technique is commonly used to secure sutures in the common femoral artery prior to upsizing the arteriotomy. Operators should be prepared to manage potential complications.


Large-bore access Preclosure Common femoral 


  1. 1.
    Obon-Dent M, Reul RM, Mortazavi A. Endovascular iliac rescue technique for complete arterial avulsion after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2014;84(2):306–10.CrossRefPubMedGoogle Scholar
  2. 2.
    MANTA Vascular Closure Device Clinical Study (MANTA). Updated 9 Jan 2017. Available from:
  3. 3.
    Haulon S, Hassen Khodja R, Proudfoot CW, Samuels E. A systematic literature review of the efficacy and safety of the Prostar XL device for the closure of large femoral arterial access sites in patients undergoing percutaneous endovascular aortic procedures. Eur J Vasc Endovasc Surg. 2011;41(2):201–13.CrossRefPubMedGoogle Scholar
  4. 4.
    Perclose ProGlide® 6F Suture-Mediated Closure (SMC) System instructions for use.: Abbott Vascular. Updated 4 May 2015. Available from:
  5. 5.
    Griese DP, Reents W, Diegeler A, Kerber S, Babin-Ebell J. Simple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2013;82(5):E734–41.CrossRefPubMedGoogle Scholar
  6. 6.
    Kiramijyan S, Magalhaes MA, Ben-Dor I, Koifman E, Escarcega RO, Baker NC, et al. The adjunctive use of Angio-Seal in femoral vascular closure following percutaneous transcatheter aortic valve replacement. EuroIntervention. 2016;12(1):88–93.CrossRefPubMedGoogle Scholar
  7. 7.
    Greenbaum AB, O’Neill WW, Paone G, Guerrero ME, Wyman JF, Cooper RL, et al. Caval–aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience. J Am Coll Cardiol. 2014;63(25 Pt A):2795–804.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.University of Toledo Medical Center, Division of Cardiovascular MedicineToledoUSA
  2. 2.University of Toledo College of MedicineToledoUSA
  3. 3.Department of Cardiovascular MedicineThe Landsman Cardiovascular CenterBurlingtonUSA
  4. 4.Comparative Effectiveness Research Institute, Lahey Hospital and Medical CenterBurlingtonUSA
  5. 5.Tufts University School of MedicineBostonUSA

Personalised recommendations